Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, Andrew Simpson, James E Neffendorf, Robert Petrarca, Katherine Alyson Muldrew, Tunde Peto, Usha Chakravarthy, Luke Membrey, Richard Haynes, Mark Costen, David H W Steel, Riti Desai, Fiona Bishop
See the full list of authors25 February 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C Gillies
25 January 2022
OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based studySimon KH Szeto, Vivian W. K. Hui, Fang Yao Tang, Dawei Yang, Zi han Sun, Shaheeda Mohamed, Carmen K M Chan, Timothy Y Y Lai, Carol Cheung
8 November 2021
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomesNeil M Bressler, Miroslav Veith, Jan Hamouz, Jan Ernest, Dominik Zalewski, Jan Studnička, Attila Vajas, András Papp, Gabor Vogt, James Luu, Veronika Matuskova, Young Hee Yoon, Tamás Pregun, Taehyung Kim, Donghoon Shin
See the full list of authors16 October 2021
Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapyMengyuan Fang, Karntida Chanwimol, Jyotsna Maram, Ghazala A Datoo O'Keefe, Charles C Wykoff, David Sarraf, A’sha Brown, Shaun Ian Retief Lampen, Brenda Zhou, Alexander M Rusakevich, SriniVas Sadda
24 September 2021
Contrast sensitivity and quality of life following intravitreal ranibizumab injection for central retinal vein occlusionTomoya Murakami, Fumiki Okamoto, Yoshimi Sugiura, Shohei Morikawa, Yoshifumi Okamoto, Takahiro Hiraoka, Tetsuro Oshika
27 August 2021
Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX studySamantha Fraser-Bell, Hyong Kwon Kang, Paul Mitchell, Jennifer J Arnold, Jodi Tainton, Susan Simonyi
25 August 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal Mehta
12 March 2021
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trialZhenquan Wu, Jinfeng Zhao, Waiching Lam, Mingmin Yang, Lu Chen, Xuelin Huang, Meirong Wei, Hui Yang, Fan Lv, Fuyan Zhang, Jian Zeng, Guo-Ming Zhang
26 February 2021
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidenceVincent Daien, Robert P Finger, James S Talks, Paul Mitchell, Tien Y Wong, Taiji Sakamoto, Bora M Eldem, Jean-François Korobelnik
31 October 2020
